India into biotechnology
Some pharma companies have diversified into biotechnology and some start-up companies engaged exclusively in biotech have achieved a significant level of success, particularly in vaccines, enzymes, monoclonal antibodies, GN-CSF (Filgrastin), Erythropoietin, Streptokinasae, Taxol derivatives, anti-ulcer drugs and bioinformatics. For instance, I would like to mention vaccine products such as tetanus, rabies, oral polio vaccine, measles, hepatitis BDPT, BCG, diphtheria toxoid, interferon, and so on produced in India in this period. In addition, animal vaccines are also being produced in large quantity. It is a fact that India is uniquely positioned in the global vaccine market, being the world’s largest producer and accounting for approximately one third of the global sales. It is believed that India will emerge as the largest supplier of vaccines and some other biotech products all over the world in the years to come.